HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/1/F269    most recent 00145.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Lee, H.-W. Articles by Kim, J. Search for Related Content PubMed PubMed Citation Articles by Lee, H.-W. Articles by Kim, J.

Sequential expression of NKCC2, TonEBP, aldose reductase, and urea transporter-A in developing mouse kidney

¹Departments of Anatomy and ²Internal Medicine, and MRC for Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea, and ³Department of Anatomy, College of Medicine, Ewha Womans University, Seoul, Korea; and ⁴Department of Medicine, University of Maryland, Baltimore, Maryland

Submitted 26 April 2006 ; accepted in final form 19 August 2006

This study was conducted to test the hypothesis that, during renal development, the Na-K-2Cl cotransporter type 2 (NKCC2) activates the tonicity-responsive enhancer binding protein (TonEBP) transcription factor by creating medullary hypertonicity. TonEBP, in turn, drives the expression of aldose reductase (AR) and urea transporter-A (UT-A). Kidneys from 13- to19-day-old fetuses (F13–F19), 1- to 21-day-old pups (P1–P21), and adult mice were examined by immunohistochemistry. NKCC2 was first detected on F14 in differentiating macula densa and thick ascending limb (TAL). TonEBP was first detected on F15 in the medullary collecting duct (MCD) and surrounding endothelial cells. AR was detected in the MCD cells of the renal medulla from F15. UT-A first appeared in the descending thin limb (DTL) on F16 and in the MCD on F18. After birth, NKCC2-positive TALs disappeared gradually from the tip of the renal papilla, becoming completely undetectable in the inner medulla on P21. TonEBP shifted from the cytoplasm to the nucleus in both vascular endothelial cells and MCD cells on P1, and its abundance increased gradually afterward. Immunoreactivity for AR and UT-A in the renal medulla increased markedly after birth. Treatment of neonatal animals with furosemide dramatically reduced expression of TonEBP, AR, and UT-A1. Furosemide also prevented the disappearance of NKCC2-expressing TALs in the papilla. The sequential expression of NKCC2, TonEBP, and its targets AR and UT-A and the reduced expression TonEBP and its targets in response to furosemide treatment support the hypothesis that local hypertonicity produced by the activity of NKCC2 activates TonEBP during development.

urinary concentration; hypertonicity; thick ascending limb; furosemide

This article has been cited by other articles:

				M. R. Dilworth, M. J. Clancy, D. Marshall, C. A. Bravery, P. E. Brenchley, and N. Ashton Development and functional capacity of transplanted rat metanephroi Nephrol. Dial. Transplant., March 1, 2008; 23(3): 871 - 879. [Abstract] [Full Text] [PDF]

				U. S. Jeon, K.-H. Han, S.-H. Park, S. D. Lee, M. R. Sheen, J.-Y. Jung, W. Y. Kim, J. M. Sands, J. Kim, and H. M. Kwon Downregulation of renal TonEBP in hypokalemic rats Am J Physiol Renal Physiol, July 1, 2007; 293(1): F408 - F415. [Abstract] [Full Text] [PDF]